NCT05590234View on ClinicalTrials.gov

Dexmedetomidine Combined With Bupivacaine for Erector Spinae Plane Block

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

July 20, 2023

Conditions
Posterior Lumbosacral Spine Fixation Surgeries
Interventions
DRUG

Dexmedetomidine injection

1ug/kg dexmedetomidine plus 20 mL of bupivacaine 0.25%

DRUG

Bupivacaine 0.25% Injectable Solution

20 ml of bupivacaine 0.25%,

DRUG

normal saline

20 ml of normal saline 0.9%.

Trial Locations (1)

12573

October 6 university hospital, Giza

All Listed Sponsors
lead

October 6 University

OTHER